11/13/2024
7:30 AM | Xenetic Biosciences (Filer)
Xenetic Biosciences, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
8:00 AM | Xenetic Biosciences (Filer)
Xenetic Biosciences, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/03/2024
11:15 PM | Xenetic Biosciences (Filer)
Xenetic Biosciences, Inc. (Filer)
| Form EFFECT | |
10/31/2024
4:00 PM | Xenetic Biosciences (Filer)
Xenetic Biosciences, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2024
3:30 PM | Xenetic Biosciences (Filer)
Xenetic Biosciences, Inc. (Filer)
| Form DEF 14A | |
10/31/2024
3:40 PM | Xenetic Biosciences (Filer)
Xenetic Biosciences, Inc. (Filer)
| Form DEFA14A | |
10/31/2024
3:50 PM | Xenetic Biosciences (Filer)
Xenetic Biosciences, Inc. (Filer)
| Form ARS | |
|
10/21/2024
4:00 PM | Xenetic Biosciences (Filer)
Xenetic Biosciences, Inc. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/14/2024
7:00 AM | Xenetic Biosciences (Filer)
Xenetic Biosciences, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
3:32 PM | Xenetic Biosciences (Filer)
Xenetic Biosciences, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/18/2024
3:11 PM | Nasdaq Stock Market LLC (Filed by)
Xenetic Biosciences (Subject)
Xenetic Biosciences, Inc. (Subject)
| Form 25-NSE | |
06/21/2024
4:00 PM | PARSLOW JAMES F (Reporting)
Xenetic Biosciences (Issuer)
Xenetic Biosciences, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
3:30 PM | Xenetic Biosciences (Filer)
Xenetic Biosciences, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2024
7:30 AM | Xenetic Biosciences (Filer)
Xenetic Biosciences, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
4:00 PM | Xenetic Biosciences (Filer)
Xenetic Biosciences, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
03/22/2024
7:00 AM | Xenetic Biosciences (Filer)
Xenetic Biosciences, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2024
4:00 PM | Xenetic Biosciences (Filer)
Xenetic Biosciences, Inc. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/18/2024
12:45 PM | CLS Therapeutics, LLC (Filed by)
Xenetic Biosciences (Subject)
Xenetic Biosciences, Inc. (Subject)
| Form SC 13D/A | |
02/12/2024
8:15 AM | Xenetic Biosciences (Filer)
Xenetic Biosciences, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2023
4:16 PM | Mizrahy Moshe (Reporting)
Xenetic Biosciences (Issuer)
Xenetic Biosciences, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/18/2023
4:18 PM | Mizrahy Moshe (Reporting)
Xenetic Biosciences (Issuer)
Xenetic Biosciences, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
4:30 PM | EISENBERG JEFFREY F (Reporting)
Xenetic Biosciences (Issuer)
Xenetic Biosciences, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
4:30 PM | PARSLOW JAMES F (Reporting)
Xenetic Biosciences (Issuer)
Xenetic Biosciences, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
4:30 PM | Lockshin Curtis (Reporting)
Xenetic Biosciences (Issuer)
Xenetic Biosciences, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/08/2023
4:30 PM | Logal Adam (Reporting)
Xenetic Biosciences (Issuer)
Xenetic Biosciences, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/08/2023
4:30 PM | VINOGRADOV ALEXEY ANDREEVICH (Reporting)
Xenetic Biosciences (Issuer)
Xenetic Biosciences, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/08/2023
4:30 PM | Callaway James Eric (Reporting)
Xenetic Biosciences (Issuer)
Xenetic Biosciences, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/08/2023
4:30 PM | Dastoor Firdaus J. (Reporting)
Xenetic Biosciences (Issuer)
Xenetic Biosciences, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/08/2023
4:30 PM | Borisenko Grigory G. (Reporting)
Xenetic Biosciences (Issuer)
Xenetic Biosciences, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/08/2023
4:30 PM | Kornberg Roger D. (Reporting)
Xenetic Biosciences (Issuer)
Xenetic Biosciences, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/08/2023
4:00 PM | Xenetic Biosciences (Filer)
Xenetic Biosciences, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
